1 Min Read
* Says signed an agreement with Pharmaseed Ltd to develop a final formulation for InMed’s inm-750
* Says under agreement, Pharmaseed will develop a final formulation for inm-750 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.